Ianire Astobiza

Bizkaia Technology Park
Derio, PV, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Loss of PGC1α drives extracellular matrix remodelling in prostate cancer through CTHRC1.

Loss of PGC1α drives extracellular matrix remodelling in prostate cancer through CTHRC1.

Journal: bioRxiv : the preprint server for biology

Published: May 18, 2026

Publisher Correction: Polyamine-dependent metabolic shielding regulates alternative splicing.

Publisher Correction: Polyamine-dependent metabolic shielding regulates alternative splicing.

Journal: Nature

Published: January 21, 2026

Correction: The PP2A regulator IER5L supports prostate cancer progression.

Correction: The PP2A regulator IER5L supports prostate cancer progression.

Journal: Cell death & disease

Published: July 22, 2025

Loss of UFMylation supports prostate cancer metastasis and rewires cell metabolism towards hexosamine biosynthesis.

Loss of UFMylation supports prostate cancer metastasis and rewires cell metabolism towards hexosamine biosynthesis.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2025

A bioinformatics screen identifies TCF19 as an aggressiveness-sustaining gene in prostate cancer.

A bioinformatics screen identifies TCF19 as an aggressiveness-sustaining gene in prostate cancer.

Journal: Molecular oncology

Published: April 16, 2025

Transcriptional network analysis of PTEN-protein-deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication.

Transcriptional network analysis of PTEN-protein-deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication.

Journal: Molecular oncology

Published: March 04, 2025

Aggressive prostate cancer is associated with pericyte dysfunction.

Aggressive prostate cancer is associated with pericyte dysfunction.

Journal: Molecular oncology

Published: February 15, 2025

Secreted spermidine synthase reveals a paracrine role for PGC1α-induced growth suppression in prostate cancer.

Secreted spermidine synthase reveals a paracrine role for PGC1α-induced growth suppression in prostate cancer.

Journal: Cell death & disease

Published: October 08, 2024

Transcriptional analysis of metastatic hormone-naïve prostate cancer primary tumor biopsies reveals a relevant role for SOX11 in prostate cancer cell dissemination.

Transcriptional analysis of metastatic hormone-naïve prostate cancer primary tumor biopsies reveals a relevant role for SOX11 in prostate cancer cell dissemination.

Journal: Genome biology

Published: August 07, 2024

Fibroblastic aspartoacylase suppresses TGFβ-mediated responses and cancer progression.

Fibroblastic aspartoacylase suppresses TGFβ-mediated responses and cancer progression.

Journal: Nature communications

Published: March 25, 2024

Polyamine-dependent metabolic shielding regulates alternative splicing.

Polyamine-dependent metabolic shielding regulates alternative splicing.

Journal: Nature

Published: January 23, 2024

The PP2A regulator IER5L supports prostate cancer progression.

The PP2A regulator IER5L supports prostate cancer progression.

Journal: Cell death & disease

Published: December 21, 2023

Showing 1-12 of 36

Last Updated: 09/26/2026